(LYM7) Multi Units France - Lyxor - Ratings and Ratios

The Lyxor MSCI Emerging Markets UCITS ETF (Ticker: LYM7), listed on XETRA, is a Germany-domiciled exchange-traded fund designed to track the performance of emerging market equities. It provides exposure to a broad range of companies across emerging economies, offering diversification benefits for investors seeking growth in developing regions. The fund is part of the Morningstar EM TME NR USD index, which includes equities from emerging markets, excluding dividend payments. As of the latest data, the ETF has an Assets Under Management (AUM) of 799.13M EUR, indicating a moderately sized fund with sufficient liquidity for most investors.

From a technical standpoint, LYM7 has shown a price of 12.63, with its 20-day average volume at 24,608 shares. The funds short-term trend, as indicated by the SMA 20, stands at 11.86, while the SMA 50 and SMA 200 are at 12.52 and 12.66, respectively. The ATR of 0.25 reflects relatively low volatility, suggesting stable price movements. The funds price is currently trading near its 200-day moving average, which may indicate a potential trend reversal or consolidation phase.

Based on the technical and fundamental data, LYM7 is expected to remain range-bound in the near term, with support at the SMA 50 (12.52) and resistance at the SMA 200 (12.66). The low ATR of 0.25 suggests that price movements will likely remain subdued, with limited upside or downside potential. However, the funds AUM of 799.13M EUR indicates a stable investor base, which may support the ETF during periods of market uncertainty.